UB-221, an antibody that neutralizes IgE and downregulates the CD23 receptor: a potential treatment for the alpha-gal syndrome.

UB-221 - United BioPharma

UB-221, an antibody that neutralizes IgE and downregulates the CD23 receptor: a potential treatment for the alpha-gal syndrome. (PubMed, Ticks Tick Borne Dis) - Oct 31, 2025 - No abstract available
Journal • FCER2

http://www.ncbi.nlm.nih.gov/pubmed/41167140

Amit K Tiwari; Charles R Ashby; Sandra E Reznik

Oct 31, 2025